In another study, Dilnawaz et al. developed HER2 antibody conjugated paclitaxel and/or rapamycin-loaded glycerol monooleate coated magnetic NPs which exhibited an enhanced uptake in the MCF-7 human breast cancer cell line. Here, ERBB2 is linked to breast carcinoma.